Key result
AI, genomics, wearables, and regenerative medicine transform cardiovascular care into a proactive, personalized approach.
Why the study?
Cardiovascular diseases remain the leading cause of mortality worldwide, necessitating continuous advancements in research and clinical practice to bridge the gap between research and clinical application.
Answers are grounded in this paper and cite their sources.
This review highlights how emerging technologies like AI, genomics, and regenerative medicine are poised to revolutionize cardiovascular care, provided implementation challenges are addressed.
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, necessitating continuous advancements in research and clinical practice. Research advancements have significantly transformed our understanding and management of CVDs. Recent breakthroughs in genomics, artificial intelligence (AI), wearable technology, and regenerative medicine are reshaping cardiovascular (CV) care. This review explores key innovations that bridge the gap between research and clinical application, emphasizing precision medicine, early detection, and personalized therapies. We also discuss challenges in implementation and future directions for optimizing CV outcomes.
No takes yet. Share an insight, caveat, or question.
Prabhash Chand Manoria (2025) conducted a review in Cardiovascular diseases. Cardiovascular care innovations (AI, genomics, wearables, regenerative medicine) was evaluated. Advancements in artificial intelligence, genomics, wearable technology, and regenerative medicine are transforming cardiovascular care from a reactive to a proactive and personalized approach.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: